FreeTender
Accepting bidstenderRussia

Закупка лекарственного препарата для лечения злокачественных образований: Трастузумаб эмтанзин (ЖНВЛП) на 2027 г.

Purchase of a drug for the treatment of malignant tumors: Trastuzumab emtanzine (VED) for 2027.English, machine translated

Issued by ДЕПАРТАМЕНТ ЭКОНОМИЧЕСКОГО РАЗВИТИЯ И ИНВЕСТИЦИОННОЙ ДЕЯТЕЛЬНОСТИ ОРЛОВСКОЙ ОБЛАСТИ · via Russia — Сбербанк-АСТ procurement (via B2B-Center/OTC aggregator)

Verify & apply on the official portal →
Published
28 Oct 2026
Closes
6 Nov 2026, 05:00 UTC
Value
RUB 42,169,760
Reference
0154200000726000866
Location
Орловская область, Russia
Sector
Healthcare & Pharma
Type
goods

At a glance

ДЕПАРТАМЕНТ ЭКОНОМИЧЕСКОГО РАЗВИТИЯ И ИНВЕСТИЦИОННОЙ ДЕЯТЕЛЬНОСТИ ОРЛОВСКОЙ ОБЛАСТИ in Russia has published a tender in healthcare & pharma: “Закупка лекарственного препарата для лечения злокачественных образований: Трастузумаб эмтанзин (ЖНВЛП) на 2027 г.”. Submissions close on 6 November 2026, 9 days from today. The stated value is RUB 42,169,760. Quote reference 0154200000726000866 in any correspondence with the buyer. FreeTender has recorded 86 notices from this buyer since 2026, 53 of them currently open. There are 21,202 open healthcare & pharma notices in Russia on FreeTender. Bids are submitted to the buyer through Russia — Сбербанк-АСТ procurement (via B2B-Center/OTC aggregator), not through FreeTender.

English summary

Machine translated from Russian by FreeTender. The original notice below is the binding text.

Subject matter of procurement: 1. trastuzumab emtanzine lyophilisate for the preparation of a concentrate for the preparation of a solution for intravenous administration 160 mg (OKPD2 21.20.10.211 - Antitumor drugs), 16 000 mg 2. trastuzumab emtanzine lyophilisate for the preparation of a concentrate for the preparation of a solution for intravenous administration of 100 mg (OKPD2 21.20.10.211 - Antitumor drugs), 20,000 mg Law: 44-FZ. Procurement method: Electronic auction. Site: JSC "Sberbank-AST". Initial (maximum) price: 42 169 760.00 .

Details

Закупка лекарственного препарата для лечения злокачественных образований: Трастузумаб эмтанзин (ЖНВЛП) на 2027 г.

Объект закупки:

1. трастузумаб эмтанзин лиофилизат для приготовления концентрата для приготовления раствора для внутривенного введения 160 мг (ОКПД2 21.20.10.211 – Препараты противоопухолевые), 16 000 мг 2. трастузумаб эмтанзин лиофилизат для приготовления концентрата для приготовления раствора для внутривенного введения 100 мг (ОКПД2 21.20.10.211 – Препараты противоопухолевые), 20 000 мг Закон: 44-ФЗ. Способ закупки: Электронный аукцион. Площадка: АО «Сбербанк-АСТ». Начальная (максимальная) цена: 42 169 760.00 ₽. Организатор: ДЕПАРТАМЕНТ ЭКОНОМИЧЕСКОГО РАЗВИТИЯ И ИНВЕСТИЦИОННОЙ ДЕЯТЕЛЬНОСТИ ОРЛОВСКОЙ ОБЛАСТИ. Регион: Орловская область. Приём заявок до: 06.11.2026 08:00 (МСК).

Извещение в ЕИС: https://zakupki.gov.ru/epz/order/notice/ea20/view/common-info.html?regNumber=0154200000726000866

Context for bidders

We hold 86 notices from ДЕПАРТАМЕНТ ЭКОНОМИЧЕСКОГО РАЗВИТИЯ И ИНВЕСТИЦИОННОЙ ДЕЯТЕЛЬНОСТИ ОРЛОВСКОЙ ОБЛАСТИ, going back to October 2026 — 53 of them still open. They buy mostly in Healthcare & Pharma, Transport & Logistics and Agriculture & Food. There are 21,202 open Healthcare & Pharma tenders in Russia. This one closes in 9 days.

More from this buyer

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →